Nanjing Leads Biolabs (09887) Announces November 2025 Share Capital Structure

Bulletin Express12-03

Nanjing Leads Biolabs Co., Ltd. (Stock code: 09887) released its monthly return for the period ended 30 November 2025, submitted on 03 December 2025. According to the filing, the total authorised and registered share capital stands at RMB 198,891,800.

The authorised and registered H shares remain at 153,278,691 shares with a par value of RMB 1 each, while unlisted ordinary shares stand at 45,613,109 shares. Both figures are unchanged from the preceding month.

No movements were reported in the issued share capital or treasury shares. The number of issued H shares remains at 153,278,691, with 45,613,109 unlisted shares. The announcement also indicates no share options, warrants, convertibles, or any other agreements for share issuance during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment